Patterns of response after preoperative treatment in gastric cancer

International Journal of Radiation Oncology Biology Physics

Volumn 80, Issue 3, 2011, Pages 698-704

  Díaz González, Juan A ^a   Rodríguez, Javier ^a   Hernández Lizoain, José L ^a   Ciérvide, Raquel ^a   Gaztañaga, Miren ^a   San Miguel, Iñigo ^a   Arbea, Leire ^a   Aristu, J Javier ^a   Chopitea, Ana ^a   Martínez Regueira, Fernando ^a   Valentí, Víctor ^a   García Foncillas, Jesús ^a   Martínez Monge, Rafael ^a   Sola, Jesús J ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Chemoradiotherapy; Gastric cancer; Neoadjuvant chemotherapy; Pathologic response; Preoperative treatment

Indexed keywords

CHEMORADIOTHERAPY; GASTRIC CANCER; NEOADJUVANT CHEMOTHERAPY; PATHOLOGIC RESPONSE; PREOPERATIVE TREATMENT;

CHEMOTHERAPY; PATHOLOGY; SURGERY; TUMORS;

DISEASES;

CAPECITABINE; CISPLATIN; DOCETAXEL; FLUOROURACIL; OXALIPLATIN; PACLITAXEL;

ADULT; ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CANCER STAGING; CANCER SURGERY; CHEMORADIOTHERAPY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; GASTRECTOMY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; STOMACH CANCER;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; NEOPLASM, RESIDUAL; REMISSION INDUCTION; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 79957574971     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.02.054     Document Type: Article

References (33)

1. J.J. Bonenkamp, J. Hermans, M. Sasako, C.J. van de Velde, K. Welvaart, and I. Songun Extended lymph-node dissection for gastric cancer N Engl J Med 340 1999 908 914 (Pubitemid 29141051)
2. S.A. Hundahl, J.L. Phillips, and H.R. Menck The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the "different disease" hypothesis Cancer 88 2000 921 932 (Pubitemid 30091113)
3. M.W. Kattan, M.S. Karpeh, M. Mazumdar, and M.F. Brennan Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma J Clin Oncol 21 2003 3647 3650 (Pubitemid 46594058)
4. J.R. Siewert, K. Bottcher, H.J. Stein, and J.D. Roder Relevant prognostic factors in gastric cancer: Ten-year results of the German Gastric Cancer Study Ann Surg 228 1998 449 461 (Pubitemid 30194389)
5. D. Cunningham, W.H. Allum, S.P. Stenning, J.N. Thompson, C.J. van de Velde, and M. Nicolson Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N Engl J Med 355 2006 11 20
6. J.A. Ajani, K. Winter, G.S. Okawara, J.H. Donohue, P.W. Pisters, and C.H. Crane Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): Quality of combined modality therapy and pathologic response J Clin Oncol 24 2006 3953 3958 (Pubitemid 46630744)
7. J.A. Ajani, P.F. Mansfield, C.H. Crane, T.T. Wu, S. Lunagomez, and P.M. Lynch Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: Degree of pathologic response and not clinical parameters dictated patient outcome J Clin Oncol 23 2005 1237 1244 (Pubitemid 46202281)
8. K. Becker, J.D. Mueller, C. Schulmacher, K. Ott, U. Fink, and R. Busch Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy Cancer 98 2003 1521 1530 (Pubitemid 37151509)
9. K. Ott, W.A. Weber, F. Lordick, K. Becker, R. Busch, and K. Herrmann Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction J Clin Oncol 24 2006 4692 4698 (Pubitemid 46646244)
10. M. Stahl, M.K. Walz, M. Stuschke, N. Lehmann, H.J. Meyer, and J. Riera-Knorrenschild Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction J Clin Oncol 27 2009 851 856
11. R. Krempien, M.W. Muenter, W. Harms, and J. Debus Neoadjuvant chemoradiation in patients with pancreatic adenocarcinoma HPB (Oxford) 8 2006 22 28 (Pubitemid 43878497)
12. R. Sauer, H. Becker, W. Hohenberger, C. Rodel, C. Wittekind, and R. Fietkau Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl.J Med 351 2004 1731 1740
13. T.N. Walsh, N. Noonan, D. Hollywood, A. Kelly, N. Keeling, and T.P. Hennessy A comparison of multimodal therapy and surgery for esophageal adenocarcinoma N Engl J Med 335 1996 462 467 (Pubitemid 26269945)
14. J.S. Macdonald, S.R. Smalley, J. Benedetti, S.A. Hundahl, N.C. Estes, and G.N. Stemmermann Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction N Engl J Med 345 2001 725 730
15. S. Kim, D.H. Lim, J. Lee, W.K. Kang, J.S. Macdonald, and C.H. Park An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach Int J Radiat Oncol Biol Phys 63 2005 1279 1285 (Pubitemid 41628018)
16. H.J. Wanebo, B.J. Kennedy, J. Chmiel, G. Steele Jr., D. Winchester, and R. Osteen Cancer of the stomach. A patient care study by the American College of Surgeons Ann Surg 218 1993 583 592 (Pubitemid 23339110)
17. C. Willett, and L.L. Gunderson Stomach E.C. Halperin, C.A. Perez, L.W. Brady, Perez and Brady's principles and practice of radiation oncology 5th ed. 2008 Lippincott Williams & Wilkins Philadelphia 1322
18. A.C. Berger, J. Farma, W.J. Scott, G. Freedman, L. Weiner, and J.D. Cheng Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival J Clin Oncol 23 2005 4330 4337 (Pubitemid 46207006)
19. L.R. Chirieac, S.G. Swisher, J.A. Ajani, R.R. Komaki, A.M. Correa, and J.S. Morris Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation Cancer 103 2005 1347 1355 (Pubitemid 40410728)
20. J.A. Diaz-Gonzalez, F.A. Calvo, J. Cortes, J.L. Garcia-Sabrido, M. Gomez-Espi, and E. Del Valle Prognostic factors for disease-free survival in patients with T3-4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation Int J Radiat Oncol Biol Phys 64 2006 1122 1128
21. J.G. Guillem, D.B. Chessin, A.M. Cohen, J. Shia, M. Mazumdar, and W. Enker Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer Ann Surg 241 2005 829 838 (Pubitemid 40604929)
22. N.A. Janjan, J. Abbruzzese, R. Pazdur, V.S. Khoo, K. Cleary, and R. Dubrow Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer Radiother Oncol 51 1999 153 160 (Pubitemid 29320309)
23. C. Rodel, P. Martus, T. Papadoupolos, L. Fuzesi, M. Klimpfinger, and R. Fietkau Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer J Clin Oncol 23 2005 8688 8696 (Pubitemid 46211512)
24. V. Valentini, C. Coco, A. Picciocchi, A.G. Morganti, L. Trodella, and A. Ciabattoni Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients Int J Radiat Oncol Biol Phys 53 2002 664 674 (Pubitemid 34626505)
25. P. Crookes, C.G. Leichman, L. Leichman, M. Tan, L. Laine, and S. Stain Systemic chemotherapy for gastric carcinoma followed by postoperative intraperitoneal therapy: A final report Cancer 79 1997 1767 1775 (Pubitemid 27176359)
26. J.A. Ajani, P.F. Mansfield, N. Janjan, J. Morris, P.W. Pisters, and P.M. Lynch Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma J Clin Oncol 22 2004 2774 2780 (Pubitemid 41079894)
27. M.C. Kaminsky-Forrett, T. Conroy, E. Luporsi, D. Peiffert, M. Lapeyre, and P. Boissel Prognostic implications of downstaging following preoperative radiation therapy for operable T3-T4 rectal cancer Int J Radiat Oncol Biol Phys 42 1998 935 941 (Pubitemid 29004132)
28. S.B. Vogel, W.M. Mendenhall, M.D. Sombeck, R. Marsh, and E.R. Woodward Downstaging of esophageal cancer after preoperative radiation and chemotherapy Ann Surg 221 1995 685 693
29. A.M. Mandard, F. Dalibard, J.C. Mandard, J. Marnay, M. Henry-Amar, and J.F. Petiot Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations Cancer 73 1994 2680 2686 (Pubitemid 24166250)
30. P.M. Schneider, S.E. Baldus, R. Metzger, M. Kocher, R. Bongartz, and E. Bollschweiler Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: Implications for response classification Ann Surg 242 2005 684 692 (Pubitemid 41567124)
31. J. Shia, J.G. Guillem, H.G. Moore, S.K. Tickoo, J. Qin, and L. Ruo Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcome Am J Surg Pathol 28 2004 215 223 (Pubitemid 38124730)
32. F.M. Vecchio, V. Valentini, B.D. Minsky, G.D. Padula, E.S. Venkatraman, and M. Balducci The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer Int J Radiat Oncol Biol Phys 62 2005 752 760 (Pubitemid 40779765)
33. J.E. Tepper, and B. O'Neil Transition in biology and philosophy in the treatment of gastroesophageal junction adenocarcinoma J Clin Oncol 27 2009 836 837